Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Improved formulation of paclitaxel in development at P&U

May 26, 1998

Enhanced antitumor activity of methotrexate using MTX-HSA conjugate

May 26, 1998

SunPharm presents phase I results of DENSPM at ASCO

May 25, 1998

Rhone-Poulenc Rorer presents new taxane in phase I testing

May 25, 1998

Neuromedica receives patent for anticancer drug

May 25, 1998

Diatide's Theratide inhibits tumor growth

May 25, 1998

Maxamine in combination with IL-2 retards prostate tumor growth in rats

May 25, 1998

Suradista, a novel distamycin derivative in phase I testing at Pharmacia & Upjohn

May 22, 1998

Capecitabine clinical data and product introduction announced at ASCO

May 22, 1998

Techniclone evaluates VEGF as a tumor marker

May 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...